Treatment Of Sleep Apnea With A Combination Of A Carbonic Anhydrase Inhibitor And An Aldosterone Antagonist


This invention relates generally to methods and pharmaceutical formulations useful in treating patients suffering from sleep apnea, including obstructive sleep apnea syndrome (OSAS). Treatment is effected by administering a carbonic anhydrase inhibitor to the patient in combination with an aldosterone antagonist. Formulations containing a therapeutically effective amount of a carbonic anhydrase inhibitor and a therapeutically effective amount of an aldosterone antagonist are provided as well.

Download PDF
Document Preview
Document History
  • Publication: Feb 18, 2016
  • Application: Aug 13, 2015
    WO US 2015/0044978 W
  • Priority: Aug 14, 2014
    US US 201462037244 P

Sign in to the Lens